acetaminophen has been researched along with Hepatitis C, Chronic in 7 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Despite abundant experimental data showing that fatty liver is more susceptible to liver injury, drug-induced liver disease seems no more frequent in NAFLD patients, except, possibly, a higher incidence but not severity of acetaminophen hepatotoxicity." | 4.90 | The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease. ( Pais, R; Ratziu, V; Rusu, E, 2014) |
| " This review summarises the evidence for potential therapeutic applications of non-immunosuppressive cyclophilin inhibitors, alone or in combination with other agents, in virus-induced liver diseases like hepatitis C, B or Delta, liver inflammation and fibrosis, acetaminophen-induced liver toxicity and hepatocellular carcinoma." | 4.90 | Cyclophilin inhibition as potential therapy for liver diseases. ( Naoumov, NV, 2014) |
| "Chronic hepatitis C was a frequent complication in patients treated for malignancy until the introduction of anti-HCV screening tests for blood donors." | 2.69 | Interferon treatment of chronic hepatitis C in patients cured of pediatric malignancies. ( Bortolotti, F; Brugiolo, A; Cesaro, S; Cusinato, R; Guido, M; Masiero, L; Petris, MG; Rossetti, F; Zanesco, L, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saadia, M | 1 |
| Sher, M | 1 |
| Bashir, S | 1 |
| Murtaza, MA | 1 |
| Shah, A | 1 |
| Khan, MA | 1 |
| Pais, R | 1 |
| Rusu, E | 1 |
| Ratziu, V | 1 |
| Weerasinghe, SV | 1 |
| Jang, YJ | 1 |
| Fontana, RJ | 1 |
| Omary, MB | 1 |
| Naoumov, NV | 1 |
| Besednova, NN | 1 |
| Zaporozhets, TS | 1 |
| Kuznetsova, TA | 1 |
| Kryzhanovskiĭ, SP | 1 |
| Kovalev, NN | 1 |
| Zviagintseva, TN | 1 |
| Szabo, G | 1 |
| Petrasek, J | 1 |
| Cesaro, S | 1 |
| Bortolotti, F | 1 |
| Petris, MG | 1 |
| Brugiolo, A | 1 |
| Cusinato, R | 1 |
| Guido, M | 1 |
| Rossetti, F | 1 |
| Masiero, L | 1 |
| Zanesco, L | 1 |
4 reviews available for acetaminophen and Hepatitis C, Chronic
| Article | Year |
|---|---|
The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease.
Topics: Acetaminophen; Anesthetics; Animals; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; He | 2014 |
Cyclophilin inhibition as potential therapy for liver diseases.
Topics: Acetaminophen; Animals; Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Cyclophil | 2014 |
[Hepatoprotective effects of extracts and polysaccharides from seaweed].
Topics: Acetaminophen; Aflatoxins; Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Li | 2014 |
Inflammasome activation and function in liver disease.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disease Prog | 2015 |
1 trial available for acetaminophen and Hepatitis C, Chronic
| Article | Year |
|---|---|
Interferon treatment of chronic hepatitis C in patients cured of pediatric malignancies.
Topics: Acetaminophen; Adolescent; Adult; Alanine Transaminase; Alopecia; Asthenia; Chlorpheniramine; DNA, V | 2000 |
2 other studies available for acetaminophen and Hepatitis C, Chronic
| Article | Year |
|---|---|
Comparative hepatoprotective effect of Nigella sativa pre- and post-treatment to rabbits.
Topics: Acetaminophen; Adult; Aged; Animals; Antioxidants; Biomarkers; Case-Control Studies; Chemical and Dr | 2019 |
Carbamoyl phosphate synthetase-1 is a rapid turnover biomarker in mouse and human acute liver injury.
Topics: Acetaminophen; Alanine Transaminase; Animals; Apoptosis; Biomarkers; Carbamoyl-Phosphate Synthase (A | 2014 |